Cargando…
Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis
Objective. To analyze serum interleukin-6 (IL-6) expression level and its clinical significance in patients with dermatomyositis. Methods. Blood samples from 23 adult patients with dermatomyositis (DM), 22 with systemic lupus erythematosus (SLE), 22 with rheumatoid arthritis (RA), 16 with Sjögren...
Autores principales: | Yang, Min, Cen, Xiaomin, Xie, Qibing, Zuo, Chuan, Shi, Guixiu, Yin, Geng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776358/ https://www.ncbi.nlm.nih.gov/pubmed/24082909 http://dx.doi.org/10.1155/2013/717808 |
Ejemplares similares
-
Association between Serum 25-Hydroxyvitamin D Level and Rheumatoid Arthritis
por: Cen, Xiaomin, et al.
Publicado: (2015) -
A Clinical Analysis of Risk Factors for Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myopathy
por: Cen, Xiaomin, et al.
Publicado: (2013) -
Elevated Serum IGFBP-2 and CTGF Levels Are Associated with Disease Activity in Patients with Dermatomyositis
por: Yang, Min, et al.
Publicado: (2022) -
Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
por: He, Chenjia, et al.
Publicado: (2022) -
Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
por: Liu, Tao, et al.
Publicado: (2017)